Literature DB >> 884920

Kinetics of intravenous theophylline.

F A Chrzanowski, P J Niebergall, R L Mayock, J M Taubin, E T Sugita.   

Abstract

The pharmacokinetics of theophylline was studied in 6 normal, nonsmoking, adult male volunteers. A constant-rate intravenous infusion of 3.84 to 4.98 mg/kg of theophylline (as the ethylenediamine salt, aminophylline) was administered over 40 min. Serum theophylline concentrations were measured for 24 hr by means of a gas chromatographic method specific for theophylline. Within 30 min of an average intravenous dose of 4.4 mg/kg of theophylline, serum levels reached 10 microgram/ml. The highest serum level at the end of the infusion was 17 microgram/ml. The serum concentration-time data were fitted to a two-compartment open model and yielded a mean serum half-life (t1/2) of 11.02 hr, a value longer than those previously reported. Our results indicated that after the original loading dose of 4.4 mg/kg was infused for 40min, an immediate infusion rate of 1.40 mg/kg/hr (1.65 mg/kg/hr aminophylline) would be necessary to maintain a serum level of 10 microgram/ml.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 884920     DOI: 10.1002/cpt1977222188

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  16 in total

1.  Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.

Authors:  Sheila Annie Peters
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 2.  The use of pharmacokinetic principles in determining the effectiveness of removal of toxins from blood.

Authors:  W J Tilstone; J F Winchester; P C Reavey
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

4.  The effect of assay methods on plasma levels and pharmacokinetics of theophylline: HPLC and EIA.

Authors:  T Ishizaki; M Watanabe; N Morishita
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

5.  Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways.

Authors:  S Dadashzadeh; H Tajerzaden
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.441

6.  Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant-rate intravenous infusion.

Authors:  W L Chiou; M A Gadalla; G W Peng
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

Review 7.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

8.  Pharmacokinetics of theophylline in patients following short-term intravenous infusion.

Authors:  V W Steinijans; R Eicke; J Ahrens
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Pharmacokinetics of theophylline: a dose-range study.

Authors:  V Rovei; F Chanoine; M Strolin Benedetti
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

10.  Urine flow-dependence of theophylline renal clearance in man.

Authors:  D D Tang-Liu; T N Tozer; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1982-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.